173 related articles for article (PubMed ID: 16174859)
1. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
Jönsson G; Bendahl PO; Sandberg T; Kurbasic A; Staaf J; Sunde L; Crüger DG; Ingvar C; Olsson H; Borg A
J Natl Cancer Inst; 2005 Sep; 97(18):1377-82. PubMed ID: 16174859
[TBL] [Abstract][Full Text] [Related]
2. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort.
Falchi M; Spector TD; Perks U; Kato BS; Bataille V
Hum Mol Genet; 2006 Oct; 15(20):2975-9. PubMed ID: 16928783
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma.
Höiom V; Tuominen R; Hansson J
Genes Chromosomes Cancer; 2011 Dec; 50(12):1076-84. PubMed ID: 21901783
[TBL] [Abstract][Full Text] [Related]
5. Localization of a novel melanoma susceptibility locus to 1p22.
Gillanders E; Juo SH; Holland EA; Jones M; Nancarrow D; Freas-Lutz D; Sood R; Park N; Faruque M; Markey C; Kefford RF; Palmer J; Bergman W; Bishop DT; Tucker MA; Bressac-de Paillerets B; Hansson J; Stark M; Gruis N; Bishop JN; Goldstein AM; Bailey-Wilson JE; Mann GJ; Hayward N; Trent J; ;
Am J Hum Genet; 2003 Aug; 73(2):301-13. PubMed ID: 12844286
[TBL] [Abstract][Full Text] [Related]
6. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.
Bale SJ; Dracopoli NC; Tucker MA; Clark WH; Fraser MC; Stanger BZ; Green P; Donis-Keller H; Housman DE; Greene MH
N Engl J Med; 1989 May; 320(21):1367-72. PubMed ID: 2716782
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.
Walker GJ; Indsto JO; Sood R; Faruque MU; Hu P; Pollock PM; Duray P; Holland EA; Brown K; Kefford RF; Trent JM; Mann GJ; Hayward NK
Genes Chromosomes Cancer; 2004 Sep; 41(1):56-64. PubMed ID: 15236317
[TBL] [Abstract][Full Text] [Related]
8. A genome screen of 35 bipolar affective disorder pedigrees provides significant evidence for a susceptibility locus on chromosome 15q25-26.
McAuley EZ; Blair IP; Liu Z; Fullerton JM; Scimone A; Van Herten M; Evans MR; Kirkby KC; Donald JA; Mitchell PB; Schofield PR
Mol Psychiatry; 2009 May; 14(5):492-500. PubMed ID: 18227837
[TBL] [Abstract][Full Text] [Related]
9. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count.
Gruis NA; Sandkuijl LA; Weber JL; van der Zee A; Borgstein AM; Bergman W; Frants RR
Melanoma Res; 1993 Aug; 3(4):271-7. PubMed ID: 8219760
[TBL] [Abstract][Full Text] [Related]
10. Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease.
Lee JH; Cheng R; Santana V; Williamson J; Lantigua R; Medrano M; Arriaga A; Stern Y; Tycko B; Rogaeva E; Wakutani Y; Kawarai T; St George-Hyslop P; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1591-8. PubMed ID: 17101828
[TBL] [Abstract][Full Text] [Related]
11. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
Goldstein AM; Dracopoli NC; Engelstein M; Fraser MC; Clark WH; Tucker MA
Am J Hum Genet; 1994 Mar; 54(3):489-96. PubMed ID: 8116618
[TBL] [Abstract][Full Text] [Related]
12. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
Molven A; Grimstvedt MB; Steine SJ; Harland M; Avril MF; Hayward NK; Akslen LA
Genes Chromosomes Cancer; 2005 Sep; 44(1):10-8. PubMed ID: 15880589
[TBL] [Abstract][Full Text] [Related]
13. Hereditary cutaneous melanoma.
Platz A; Ringborg U; Hansson J
Semin Cancer Biol; 2000 Aug; 10(4):319-26. PubMed ID: 10966854
[TBL] [Abstract][Full Text] [Related]
14. A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q.
Dauvilliers Y; Blouin JL; Neidhart E; Carlander B; Eliaou JF; Antonarakis SE; Billiard M; Tafti M
Ann Neurol; 2004 Sep; 56(3):382-8. PubMed ID: 15349865
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide scanning for linkage in Finnish breast cancer families.
Huusko P; Juo SH; Gillanders E; Sarantaus L; Kainu T; Vahteristo P; Allinen M; Jones M; Rapakko K; Eerola H; Markey C; Vehmanen P; Gildea D; Freas-Lutz D; Blomqvist C; Leisti J; Blanco G; Puistola U; Trent J; Bailey-Wilson J; Winqvist R; Nevanlinna H; Kallioniemi OP
Eur J Hum Genet; 2004 Feb; 12(2):98-104. PubMed ID: 14560309
[TBL] [Abstract][Full Text] [Related]
16. Investigation of a putative melanoma susceptibility locus at chromosome 3q29.
Tuominen R; Jönsson G; Enerbäck C; Appelqvist F; Olsson H; Ingvar C; Hansson J; Höiom V
Cancer Genet; 2014 Mar; 207(3):70-4. PubMed ID: 24721441
[TBL] [Abstract][Full Text] [Related]
17. Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21.
Cannon-Albright LA; Teerlink CC; Farnham JM; Thomas AW; Zone JJ; Leachman SA
J Invest Dermatol; 2013 Jan; 133(1):128-34. PubMed ID: 22951724
[TBL] [Abstract][Full Text] [Related]
18. Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population.
Lamperska K; Karezewska A; Kwiatkowska E; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):369-76. PubMed ID: 12362978
[TBL] [Abstract][Full Text] [Related]
19. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22.
Moses EK; Fitzpatrick E; Freed KA; Dyer TD; Forrest S; Elliott K; Johnson MP; Blangero J; Brennecke SP
Mol Hum Reprod; 2006 Aug; 12(8):505-12. PubMed ID: 16809377
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor.
Pujana MA; Ruiz A; Badenas C; Puig-Butille JA; Nadal M; Stark M; Gómez L; Valls J; Solé X; Hernández P; Cerrato C; Madrigal I; de Cid R; Aguilar H; Capellá G; Cal S; James MR; Walker GJ; Malvehy J; Milà M; Hayward NK; Estivill X; Puig S
Genes Chromosomes Cancer; 2007 Feb; 46(2):155-62. PubMed ID: 17099875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
